Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Pharmacokinetics of Phenytoin: Reminders and Discoveries
Epilepsy Currents, 07/08/09
Bergen DC - Healthy elderly adults appear to have the same phenytoin (PHT) pharmacokinetics as younger adults. Reduced PHT dosage requirements may be due to age-related changes in patients' sensitivity to the therapeutic and toxic effects of the drug. The prolonged elimination half-life suggests that most patients can take PHT once daily and the time to reach steady-state may extend to 2–3 weeks.
Related Articles
Phenytoin toxicity and thyroid dysfunction
New Zealand Medical Journal, 10/08/09
Relevance Score: 89%
Unusual presentation of iatrogenic phenytoin toxicity in a newborn
Journal of Medical Toxicology, 11/11/09
Relevance Score: 88%
Phenytoin-facilitated hypoglycaemia in ESRF
British Journal of Renal Medicine, 10/26/09
Relevance Score: 88%
Utility of levetiracetam in patients with subarachnoid hemorrhage
Seizure - European Journal of Epilepsy, 10/30/09
Relevance Score: 80%
Anticonvulsant Use and Outcomes After Intracerebral Hemorrhage
Stroke, 10/08/09
Relevance Score: 80%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease
Acta Neurologica Scandinavica, 12/01/09
Systematic review of apomorphine infusion, levodopa infusion and deep brain stimulation in advanced Parkinsons disease
Parkinsonism & Related Disorders, 12/01/09
Effectiveness and tolerability of zonisamide in children with epilepsy: A retrospective review
Seizure - European Journal of Epilepsy, 12/01/09
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Pharmacokinetic—pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide
Clinical Therapeutics, 12/01/09
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II
Clinical Pharmacokinetics, 12/01/09
Pharmacokinetics, metabolism and bioavailability of the triazole antifungal agent voriconazole in relation to CYP2C19 genotype
British Journal of Clinical Pharmacology, 11/30/09
Sponsor
Article Search
Sponsor


See Latest Articles


